c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-gamma1 and negatively regulates its transcriptional activity - PubMed (original) (raw)

c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-gamma1 and negatively regulates its transcriptional activity

H S Camp et al. Endocrinology. 1999 Jan.

Abstract

The peroxisome proliferator-activated receptor-gamma (PPARgamma) transcription factor plays a pivotal role in adipocyte differentiation and metabolic regulation. The transcriptional activity of PPARgamma is positively modulated by ligand binding and negatively regulated by phosphorylation mediated by the MEK/ERK signaling pathway. The phosphorylation of mouse PPARgamma1 at Ser82 by ERK causes a decrease in both basal and ligand-dependent transcriptional activity. In this report we examined the ability of other mitogen-activated protein kinase family members to phosphorylate PPARgamma1. We demonstrate that in vitro, PPARgamma1 is efficiently phosphorylated by JNK/SAPK (c-Jun N-terminal kinase or stress-activated protein kinase) but only weakly phosphorylated by p38. In transfected 293T cells, PPARgamma1 is phosphorylated at Ser82 in response to known JNK activators such as UV irradiation and anisomycin treatment. This phosphorylation is not blocked by either the specific MEK inhibitor PD98059 or the p38 inhibitor SB203580, indicating that it is independent of the MEK/ERK and p38 signaling pathways. Finally, in transient transfection reporter assays, activation of JNK by anisomycin or by overexpression of MKK4 (the upstream JNK kinase) decreased ligand-dependent PPARgamma1 transcriptional activity. These results suggest that the activation of the JNK/SAPK pathway by extracellular signals, perhaps by inflammatory cytokines such as tumor necrosis factor-alpha, would result in a reduction of PPARgamma transcriptional activity and reduce the effects of PPARgamma ligands.

PubMed Disclaimer

Cited by

Gene expression profiling of bovine in vitro adipogenesis using a cDNA microarray.
Tan SH, Reverter A, Wang Y, Byrne KA, McWilliam SM, Lehnert SA. Tan SH, et al. Funct Integr Genomics. 2006 Jul;6(3):235-49. doi: 10.1007/s10142-005-0016-x. Epub 2006 Feb 10. Funct Integr Genomics. 2006. PMID: 16470362
Peroxisome proliferator activated receptor-γ and the ubiquitin-proteasome system in colorectal cancer.
Voutsadakis IA. Voutsadakis IA. World J Gastrointest Oncol. 2010 May 15;2(5):235-41. doi: 10.4251/wjgo.v2.i5.235. World J Gastrointest Oncol. 2010. PMID: 21160623 Free PMC article.
Micromolar changes in lysophosphatidylcholine concentration cause minor effects on mitochondrial permeability but major alterations in function.
Hollie NI, Cash JG, Matlib MA, Wortman M, Basford JE, Abplanalp W, Hui DY. Hollie NI, et al. Biochim Biophys Acta. 2014 Jun;1841(6):888-95. doi: 10.1016/j.bbalip.2013.11.013. Epub 2013 Dec 5. Biochim Biophys Acta. 2014. PMID: 24315825 Free PMC article.
F-box only protein 9 is an E3 ubiquitin ligase of PPARγ.
Lee KW, Kwak SH, Koo YD, Cho YK, Lee HM, Jung HS, Cho YM, Park YJ, Chung SS, Park KS. Lee KW, et al. Exp Mol Med. 2016 May 20;48(5):e234. doi: 10.1038/emm.2016.31. Exp Mol Med. 2016. PMID: 27197753 Free PMC article.
Ginsenoside Rg1 promotes β‑amyloid peptide degradation through inhibition of the ERK/PPARγ phosphorylation pathway in an Alzheimer's disease neuronal model.
Quan Q, Ma X, Li M, Li X, Yuan H. Quan Q, et al. Exp Ther Med. 2023 Nov 23;27(1):31. doi: 10.3892/etm.2023.12319. eCollection 2024 Jan. Exp Ther Med. 2023. PMID: 38125359 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- The Lens - Patent Citations Database
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal

c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-gamma1 and negatively regulates its transcriptional activity - PubMed (original) (raw)